Savara (SVRA) Receivables - Other (2010 - 2013)

Savara (SVRA) posted quarterly Receivables - Other of $29185.0 for Q3 2013, up 186.92% year-over-year from $10172.0 in Q3 2012, and up 202.15% quarter-over-quarter from $9659.0 in Q2 2013.

Savara (SVRA) Receivables - Other (2010 - 2013) Analysis & Trends

Savara (SVRA) has reported Receivables - Other for 4 consecutive years, with $29185.0 the latest figure, recorded in Q3 2013.

  • In Q3 2013, Receivables - Other rose 186.92% year-over-year to $29185.0; the TTM figure through Sep 2013 stood at $29185.0 (up 186.92% YoY), while the FY2012 annual figure was $15689.0, down 9.02% from the prior year.
  • Receivables - Other grew to $29185.0 in Q3 2013 per SVRA's latest filing, from $9659.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $29185.0 in Q3 2013 and bottomed at $271.0 in Q2 2011.
  • Historically, Receivables - Other has averaged $12580.6 across 4 years, with a median of $10831.0 in 2013.
  • Annual changes were most pronounced in 2012 — Receivables - Other surged 7849.45% — and 2013, when it plunged 55.16%.
  • Savara's Receivables - Other stood at $1980.0 in 2010, then jumped by 770.96% to $17245.0 in 2011, then declined by 9.02% to $15689.0 in 2012, then soared by 86.02% to $29185.0 in 2013.
  • Business Quant data shows SVRA's Receivables - Other at $29185.0 in Q3 2013, $9659.0 in Q2 2013, and $10831.0 in Q1 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Savara 1.11 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2013 29,185.00
Sep 30, 2013 29,185.00
Jun 30, 2013 9,659.00
Jun 30, 2013 9,659.00
Mar 31, 2013 10,831.00
Mar 31, 2013 10,831.00
Dec 31, 2012 15,689.00
Dec 31, 2012 15,689.00
Sep 30, 2012 10,172.00
Sep 30, 2012 10,172.00
Jun 30, 2012 21,543.00
Jun 30, 2012 21,543.00
Mar 31, 2012 14,943.00
Mar 31, 2012 14,943.00
Dec 31, 2011 17,245.00
Dec 31, 2011 17,245.00
Sep 30, 2011 6,869.00
Sep 30, 2011 6,869.00
Jun 30, 2011 271.00
Jun 30, 2011 271.00